Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma
oleh: Domenica Lorusso, Domenica Lorusso, Romano Danesi, Laura Deborah Locati, Laura Deborah Locati, Gianluca Masi, Gianluca Masi, Ugo De Giorgi, Angiolo Gadducci, Sandro Pignata, Roberto Sabbatini, Antonella Savarese, Giorgio Valabrega, Claudio Zamagni, Nicoletta Colombo, Nicoletta Colombo
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2023-08-01 |
Deskripsi
Subjek
lenvatinib; pembrolizumab; endometrial cancer; tyrosine kinase inhibitor; immune response